![Michael Lutz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Lutz
Vorstandsvorsitzender bei
Iota Sciences Ltd.
Profil
Michael Lutz currently works at Iota Sciences Ltd., as Chief Executive Officer & Director from 2023, 2cureX ApS, as Director from 2020, and Noscendo GmbH, as Director.
Dr. Lutz also formerly worked at HepaRegeniX GmbH, as Chief Executive Officer & Managing Director, NTP Nano Tech Projects SRL, as Executive Chairman, Lophius Biosciences GmbH, as Managing Director, and 2cureX AB, as Independent Director from 2020 to 2023.
Dr. Lutz received his doctorate degree from Swiss Federal Institute of Technology.
Aktive Positionen von Michael Lutz
| Unternehmen | Position | Beginn |
|---|---|---|
2cureX ApS
 2cureX ApS Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs and technology for the treatment of cancer | Direktor/Vorstandsmitglied | 01.01.2020 |
Noscendo GmbH
 Noscendo GmbH Medical SpecialtiesHealth Technology Develops bioinformatics solutions for identifying and assess pathogens in bloodstream associated & related infections | Direktor/Vorstandsmitglied | - |
Iota Sciences Ltd.
 Iota Sciences Ltd. Packaged SoftwareTechnology Services Develops fluid-shaping technology for life sciences and biomedicine, offering innovative solutions for ambitious research | Vorstandsvorsitzender | 01.12.2022 |
Ehemalige bekannte Positionen von Michael Lutz
| Unternehmen | Position | Ende |
|---|---|---|
| 2CUREX AB | Direktor/Vorstandsmitglied | 01.02.2023 |
NTP Nano Tech Projects SRL
 NTP Nano Tech Projects SRL Miscellaneous Commercial ServicesCommercial Services Develops advanced optical-laser microscopy technologies and devices | Vorsitzender | - |
HepaRegeniX GmbH
 HepaRegeniX GmbH BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops novel therapies for the treatment of acute and chronic liver diseases | Vorstandsvorsitzender | - |
Lophius Biosciences GmbH
 Lophius Biosciences GmbH BiotechnologyHealth Technology Develops t-cell-based diagnostic tests and provides novel solutions for infectious diseases | Vorstandsvorsitzender | - |
Ausbildung von Michael Lutz
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
7
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Swiss Federal Institute of Technology
 Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs and technology for the treatment of cancer | Health Technology |
Lophius Biosciences GmbH
Lophius Biosciences GmbH BiotechnologyHealth Technology Develops t-cell-based diagnostic tests and provides novel solutions for infectious diseases | Health Technology |
HepaRegeniX GmbH
HepaRegeniX GmbH BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops novel therapies for the treatment of acute and chronic liver diseases | Health Technology |
Iota Sciences Ltd.
Iota Sciences Ltd. Packaged SoftwareTechnology Services Develops fluid-shaping technology for life sciences and biomedicine, offering innovative solutions for ambitious research | Technology Services |
NTP Nano Tech Projects SRL
NTP Nano Tech Projects SRL Miscellaneous Commercial ServicesCommercial Services Develops advanced optical-laser microscopy technologies and devices | Commercial Services |
2cureX AB
 2cureX AB Medical SpecialtiesHealth Technology Develops and supplies in vitro diagnostic (IVD) devices | Health Technology |
Noscendo GmbH
Noscendo GmbH Medical SpecialtiesHealth Technology Develops bioinformatics solutions for identifying and assess pathogens in bloodstream associated & related infections | Health Technology |
